Finn Laura, Green Alva Roche, Malhotra Sonia
Division of Hematology and Bone Marrow Transplant, Department of Internal Medicine, Ochsner Clinic Foundation, New Orleans, LA.
Division of Palliative Medicine, Department of Family Medicine, Mayo Clinic, Jacksonville, FL.
Ochsner J. 2017 Winter;17(4):393-397.
Despite the evidence for the fundamental need for palliative medicine services in the practice of oncology, integration of these medical specialties remains a clinical challenge.
We reviewed the current literature regarding the practice of palliative medicine in the field of oncology, examining randomized clinical trials of palliative medicine services in advanced cancer, models of palliative medicine delivery, studies of cost effectiveness, and national palliative medicine practice and referral guidelines. In this review, we describe the role of palliative medicine in oncology, including the timing of palliative medicine consultation, models of care delivery, and improvements in patient outcomes.
Randomized controlled trials and national guidelines support early referral of patients with cancer to palliative medicine. Palliative medicine has a fundamental role in symptom management, distress relief, family and caregiver support, and advance care planning. Integration of palliative medicine in oncology improves patient outcomes and decreases healthcare costs. Early involvement of palliative medicine after the cancer diagnosis is supported by national guidelines, but barriers include variable referral patterns among oncologists and the need for an expanded palliative medicine workforce.
Palliative medicine has a wide-ranging role in the spectrum of comprehensive cancer care-from patient diagnosis to survivorship. The entire multidisciplinary care team has a role in providing palliative care in inpatient and outpatient settings. An effective palliative medicine and oncology collaboration improves patient care and quality of life, has broad research and guideline support, and is cost effective.
尽管有证据表明肿瘤学实践中对姑息医学服务有根本需求,但这些医学专科的整合仍然是一项临床挑战。
我们回顾了当前关于肿瘤学领域姑息医学实践的文献,研究了晚期癌症姑息医学服务的随机临床试验、姑息医学提供模式、成本效益研究以及国家姑息医学实践和转诊指南。在本综述中,我们描述了姑息医学在肿瘤学中的作用,包括姑息医学咨询的时机、护理提供模式以及患者结局的改善。
随机对照试验和国家指南支持将癌症患者早期转诊至姑息医学。姑息医学在症状管理、缓解痛苦、支持家庭和照顾者以及预先护理计划方面具有根本作用。将姑息医学整合到肿瘤学中可改善患者结局并降低医疗成本。国家指南支持在癌症诊断后早期引入姑息医学,但障碍包括肿瘤学家之间不同的转诊模式以及需要扩大姑息医学专业人员队伍。
姑息医学在综合癌症护理的整个范围内具有广泛作用——从患者诊断到生存。整个多学科护理团队在住院和门诊环境中都有提供姑息治疗的作用。有效的姑息医学与肿瘤学合作可改善患者护理和生活质量,得到广泛的研究和指南支持,并且具有成本效益。